Maravai LifeSciences Holdings, Inc. Class A Common Stock

MRVINASDAQUSD
6.90 USD
0.02 (0.22%)🟢LIVE (AS OF 12:07 PM EDT)
🟢Market: OPEN

Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is currently trading at $6.90. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". This is driven by negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, MRVI trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Sep 15, 2026.

Open?$6.90
High?$7.27
Low?$6.87
Prev. Close?$6.88
Volume?593.2K
Avg. Volume?4.0M
VWAP?$6.96
Rel. Volume?0.15x
Bid / Ask
Bid?$6.88 × 600
Ask?$6.89 × 600
Spread?$0.01
Midpoint?$6.89
Valuation & Ratios
Market Cap?1.0B
Shares Out?149.0M
Float?124.6M
Float %?83.7%
P/E Ratio?N/A
P/B Ratio?5.01
EPS?-$0.52
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Employees
415
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-11-20
Address
10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA 92121
Phone: (858) 546-0004
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
50
Momentum?
50
Short Sent.?
56
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.40Grey
Confidence?75%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.80%Elevated
Short Interest?11.0M
Days to Cover?1.7
Free Float124.6M
Avg Daily Volume6.6M
Settlement Date2026-08-31
Financial Health
Current Ratio?4.05Strong
Quick Ratio?2.98Strong
Cash Ratio?1.82Strong
Debt/Equity?0.86Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A
P/B?
Peers
100
S&P
37
5.01FAIR
P/S?
Peers
100
S&P
30
4.91FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-51.9CHEAP
EV/Sales?
Peers
100
S&P
33
5.42FAIR
Returns & Efficiency
ROE?
S&P
3
-37.8%WEAK
ROA?
S&P
3
-12.8%WEAK
Cash Flow & Enterprise
FCF?$-35108000
Enterprise Value?$1.1B
Fundamentals ratios updated end of day